Related Experiment Videos
Selective IgA deficiency combined with immune thrombocytopenic purpura in pregnancy--problems in management
1Department of Obstetrics and Gynaecology, Beilinson Medical Centre, Petah Tiqa, Israel.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A latent profile analysis of PTSD symptoms among UK treatment seeking veterans.
European journal of psychotraumatology·2019
Post-traumatic growth in (ex-) military personnel: review and qualitative synthesis.
Occupational medicine (Oxford, England)·2018
The impact of military service on health and well-being.
Occupational medicine (Oxford, England)·2018
Mental health service acceptability for the armed forces veteran community.
Occupational medicine (Oxford, England)·2018
Experiences and career intentions of combat-deployed UK military personnel.
Occupational medicine (Oxford, England)·2018
The effect of labour and maternal oxytocin infusion on fetal plasma oxytocin concentration.
British journal of obstetrics and gynaecology·1999
Inconsistencies in classification by experts of cardiotocograms and subsequent clinical decision.
British journal of obstetrics and gynaecology·1999
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.
British journal of obstetrics and gynaecology·1999
Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity.
British journal of obstetrics and gynaecology·1999
Isolated fetal echogenic intracardiac foci or golf balls: is karyotyping for Down's syndrome indicated?
British journal of obstetrics and gynaecology·1999
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
British journal of obstetrics and gynaecology·1999
Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.
Pharmaceuticals (Basel, Switzerland)·2026
Targeting HMGB1 for Renal Ischemia and Reperfusion Injury: Mechanisms and Therapeutic Strategies.
Pharmaceuticals (Basel, Switzerland)·2026